These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37536990)

  • 21. Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of
    Nantongo M; Nguyen DC; Bethel CR; Taracila MA; Li Q; Dousa KM; Shin E; Kurz SG; Nguyen L; Kreiswirth BN; Boom WH; Plummer MS; Bonomo RA
    ACS Infect Dis; 2024 May; 10(5):1767-1779. PubMed ID: 38619138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution.
    Gonzalo X; Satta G; Ortiz Canseco J; McHugh TD; Drobniewski F
    BMC Microbiol; 2020 Aug; 20(1):271. PubMed ID: 32867678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam.
    Bonnin RA; Bernabeu S; Emeraud C; Creton E; Vanparis O; Naas T; Jousset AB; Dortet L
    Int J Antimicrob Agents; 2022 Oct; 60(4):106660. PubMed ID: 35988666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The
    Fröberg G; Ahmed A; Chryssanthou E; Davies Forsman L
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0052823. PubMed ID: 37671880
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Yamatani I; Aono A; Fujiwara K; Asami T; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Komiya K; Mitarai S
    Microbiol Spectr; 2024 Jul; 12(7):e0008424. PubMed ID: 38842354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia.
    Biagi M; Lamm D; Meyer K; Vialichka A; Jurkovic M; Patel S; Mendes RE; Bulman ZP; Wenzler E
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32928733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis.
    Hugonnet JE; Tremblay LW; Boshoff HI; Barry CE; Blanchard JS
    Science; 2009 Feb; 323(5918):1215-8. PubMed ID: 19251630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uncovering Beta-Lactam Susceptibility Patterns in Clinical Isolates of Mycobacterium tuberculosis through Whole-Genome Sequencing.
    Olivença F; Nunes A; Macedo R; Pires D; Silveiro C; Anes E; Miragaia M; Gomes JP; Catalão MJ
    Microbiol Spectr; 2022 Aug; 10(4):e0067422. PubMed ID: 35695524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revisiting the β-Lactams for Tuberculosis Therapy with a Compound-Compound Synthetic Lethality Approach.
    Xiao S; Guo H; Weiner WS; Maddox C; Mao C; Gunosewoyo H; Pelly S; White EL; Rasmussen L; Schoenen FJ; Aubé J; Bishai WR; Lun S
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
    Cavanaugh JS; Jou R; Wu MH; Dalton T; Kurbatova E; Ershova J; Cegielski JP;
    J Antimicrob Chemother; 2017 Jun; 72(6):1678-1687. PubMed ID: 28333192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales.
    Bonnin RA; Bernabeu S; Emeraud C; Naas T; Girlich D; Jousset AB; Dortet L
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671303
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Nelson K; Rubio-Aparicio D; Sun D; Dudley M; Lomovskaya O
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32482673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New β-Lactamase Inhibitors Nacubactam and Zidebactam Improve the
    Kaushik A; Ammerman NC; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imipenem/relebactam activity compared to other antimicrobials against non-MBL-producing carbapenem-resistant Enterobacteriaceae from an academic medical center.
    Kulengowski B; Burgess DS
    Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31365075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
    Sharma AK; Vats P
    Indian J Tuberc; 2019 Jan; 66(1):92-98. PubMed ID: 30797291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen.
    Singh S; Gumbo T; Alffenaar JW; Boorgula GD; Shankar P; Thomas TA; Dheda K; Malinga L; Raj P; Aryal S; Srivastava S
    Int J Antimicrob Agents; 2023 Dec; 62(6):106968. PubMed ID: 37726063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae.
    Tselepis L; Langley GW; Aboklaish AF; Widlake E; Jackson DE; Walsh TR; Schofield CJ; Brem J; Tyrrell JM
    Int J Antimicrob Agents; 2020 Jul; 56(1):105925. PubMed ID: 32084512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.
    Soroka D; Li de la Sierra-Gallay I; Dubée V; Triboulet S; van Tilbeurgh H; Compain F; Ballell L; Barros D; Mainardi JL; Hugonnet JE; Arthur M
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5714-20. PubMed ID: 26149997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imipenem-Relebactam Susceptibility in
    Hernández-García M; García-Castillo M; Bou G; Cercenado E; Delgado-Valverde M; Oliver A; Pitart C; Rodríguez-Lozano J; Tormo N; Melo-Cristino J; Pinto MF; Gonçalves E; Alves V; Vieira AR; Ramalheira E; Sancho L; Diogo J; Ferreira R; Cruz H; Chaves C; Duarte J; Pássaro L; Díaz-Regañón J; Cantón R
    Microbiol Spectr; 2022 Oct; 10(5):e0292722. PubMed ID: 36043877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in
    Zhou J; Qian Y; Lang Y; Zhang Y; Tao X; Moya B; Sayed ARM; Landersdorfer CB; Shin E; Werkman C; Smith NM; Kim TH; Kumaraswamy M; Shin BS; Tsuji BT; Bonomo RA; Lee RE; Bulitta JB
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0139923. PubMed ID: 38329330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.